TA212 Colorectal cancer (metastatic) - bevacizumab: Appendix B - proposal paper presented to the Institute's Guidance Executive
TA212 Colorectal cancer (metastatic) - bevacizumab: Appendix B - proposal paper presented to the Institute's Guidance Executive
13 May 2013 (274.68 Kb 20 sec) |
This page was last updated: 10 May 2013